Welcome to the Grant for Oncology Innovation

Please note that the application phase for the GOI 2017 will be delayed. Please check this site for future updates.

The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono, a business of Merck KGaA, Darmstadt, Germany, which aims to support the advancement of science and medical research in the field of personalized treatment for solid tumors. The grant program was first launched to coincide with the European Cancer Congress (ECCO-ESMO-ESTRO) in Amsterdam, September 27 - October 1, 2013.

The three winners of the first GOI award were announced during an Awards Ceremony that took place in Madrid, Spain on Friday, September 26, 2014.

The three winners of the second GOI award were announced during an Awards Ceremony that took place in Vienna on Friday, September 25, 2015.

The three winners of the third GOI award were announced during an Awards Ceremony that took place in Copenhagen on Sunday, October 9, 2016.

Please note that the application phase for the GOI 2017 will be delayed. Please check this site for future updates.